ADMA Biologics (ADMA) PT Lowered to $18 at Canaccord
Tweet
Share
E-mailGet Alerts ADMA Hot Sheet
Price: $8.70 +0.12%
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 1 | New: 2
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 1 | New: 2
Join SI Premium – FREE
Canaccord analyst Gary Nachmann lowered the price target on ADMA Biologics (NASDAQ: ADMA) to $18.00 (from $21.00) while maintaining a Buy rating.
You May Also Be Interested In
- ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
- Telecom Plus Plc. (TEP:LN) PT Lowered to GBP12 at Berenberg
- Douglas AG (DOU:GR) PT Lowered to EUR14.20 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
